Human Patient-Derived Colorectal Cancer Organoid – Rectum is a 3D in vitro tumor model derived from resected rectal cancer tissue. This organoid closely mimics the histological and genetic characteristics of rectal tumors, preserving the patient-specific architecture, mutational profile, and growth dynamics. Cultured under defined conditions, it supports long-term expansion and maintains tumor heterogeneity, enabling accurate simulation of the rectal tumor microenvironment. It serves as a reliable and physiologically relevant platform for investigating rectal cancer biology and therapeutic responses.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. Human Patient-Derived Colorectal Cancer Organoid – Rectum is ideally suited for evaluating treatment strategies specific to rectal cancer, including chemoradiotherapy responses and combination drug regimens. It facilitates studies on tumor progression, resistance mechanisms, and the identification of predictive biomarkers. Additionally, it supports the development of individualized treatment approaches by replicating patient-specific tumor features in vitro, making it a critical tool in precision oncology and translational colorectal cancer research.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.